Fig. 6: Outcomes of patients according to the proposed refinement of the ELN-2022 classification.
A Relapse-free survival and B overall survival in the entire cohort of 1 118 patients.
Fig. 6: Outcomes of patients according to the proposed refinement of the ELN-2022 classification. | Leukemia
